KalVista Pharmaceuticals, Inc. (KALV): Price and Financial Metrics
KALV Price/Volume Stats
| Current price | $13.80 | 52-week high | $15.50 |
| Prev. close | $13.54 | 52-week low | $7.30 |
| Day low | $13.41 | Volume | 418,500 |
| Day high | $13.81 | Avg. volume | 516,601 |
| 50-day MA | $12.08 | Dividend yield | N/A |
| 200-day MA | $10.90 | Market Cap | 686.08M |
KALV Stock Price Chart Interactive Chart >
KalVista Pharmaceuticals, Inc. (KALV) Company Bio
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors. The companys product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. The company is based in Cambridge, Massachusetts.
KALV Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
KALV Price Returns
| 1-mo | 12.65% |
| 3-mo | 15.77% |
| 6-mo | 40.67% |
| 1-year | 16.46% |
| 3-year | 55.93% |
| 5-year | 17.85% |
| YTD | 62.93% |
| 2024 | -30.86% |
| 2023 | 81.21% |
| 2022 | -48.90% |
| 2021 | -30.33% |
| 2020 | 6.63% |